Celldex Therapeutics, Inc. (CLDX)
39.30
+0.06
(+0.15%)
USD |
NASDAQ |
Sep 02, 13:58
Celldex Therapeutics Total Liabilities (Quarterly) : 67.78M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 67.78M |
| March 31, 2026 | 55.03M |
| December 31, 2025 | 55.82M |
| September 30, 2025 | 50.08M |
| June 30, 2025 | 37.00M |
| March 31, 2025 | 36.49M |
| December 31, 2024 | 45.34M |
| September 30, 2024 | 37.27M |
| June 30, 2024 | 31.93M |
| March 31, 2024 | 30.23M |
| December 31, 2023 | 36.46M |
| September 30, 2023 | 33.54M |
| June 30, 2023 | 21.77M |
| March 31, 2023 | 21.78M |
| December 31, 2022 | 26.53M |
| September 30, 2022 | 23.81M |
| June 30, 2022 | 37.87M |
| March 31, 2022 | 25.94M |
| December 31, 2021 | 25.18M |
| September 30, 2021 | 23.49M |
| June 30, 2021 | 22.27M |
| March 31, 2021 | 24.90M |
| December 31, 2020 | 26.48M |
| September 30, 2020 | 25.80M |
| June 30, 2020 | 22.96M |
| Date | Value |
|---|---|
| March 31, 2020 | 28.80M |
| December 31, 2019 | 28.91M |
| September 30, 2019 | 30.46M |
| June 30, 2019 | 32.62M |
| March 31, 2019 | 34.88M |
| December 31, 2018 | 31.75M |
| September 30, 2018 | 40.15M |
| June 30, 2018 | 50.33M |
| March 31, 2018 | 57.29M |
| December 31, 2017 | 79.26M |
| September 30, 2017 | 100.27M |
| June 30, 2017 | 114.61M |
| March 31, 2017 | 112.21M |
| December 31, 2016 | 117.93M |
| September 30, 2016 | 34.86M |
| June 30, 2016 | 36.50M |
| March 31, 2016 | 41.90M |
| December 31, 2015 | 47.48M |
| September 30, 2015 | 34.00M |
| June 30, 2015 | 37.34M |
| March 31, 2015 | 32.15M |
| December 31, 2014 | 36.35M |
| September 30, 2014 | 32.29M |
| June 30, 2014 | 32.28M |
| March 31, 2014 | 26.85M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 37.62B |
| Ionis Pharmaceuticals, Inc. | 2.555B |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 782.35M |
| Shareholders Equity (Quarterly) | 714.56M |
| Debt to Equity Ratio | 0.0069 |
| Current Ratio | 11.82 |
| Net Debt Paydown Yield | -0.01% |